2 replies [Last post]
Joined: 05/19/2009
Groups: Contenders

Jan 8 2018 "NEW YORK (Reuters) - Pfizer Inc (PFE.N) is abandoning research to find new drugs aimed at treating Alzheimer’s and Parkinson’s disease, the U.S. pharmaceutical company announced on Saturday.

The company said it expects to eliminate 300 positions from the neuroscience discovery and early development programs in Andover and Cambridge, Massachusetts, and Groton, Connecticut, as it redistributes the money spent on research, according to the emailed statement.


Joined: 05/19/2009
Groups: Contenders
Also read up on their recent $38.8 billion tax cut.
jeff101's picture
User offline. Last seen 19 hours 37 min ago. Offline
Joined: 04/20/2012
Groups: Go Science
Thanks for sharing those articles.

Maybe someone better will take Pfizer's place in those markets
and/or hire all those displaced neuroscience researchers.
Maybe some of those displaced researchers will take the
plunge into entrepreneurship themselves. Maybe some will
start playing Foldit!


Developed by: UW Center for Game Science, UW Institute for Protein Design, Northeastern University, Vanderbilt University Meiler Lab, UC Davis
Supported by: DARPA, NSF, NIH, HHMI, Amazon, Microsoft, Adobe, Boehringer Ingelheim, RosettaCommons